Insights On Drug Development
-
mRNA Therapeutic Development Through Enhanced IVT Capping Efficiency
4/16/2025
See how Codex HiCap RNA Polymerase supports the production of high-performance synthetic mRNA, paving the way for next-generation mRNA therapies.
-
Challenges In ADC Production - Consolidating Operations Under One Roof
4/15/2025
Eurofins CDMO Alphora consolidates ADC development and manufacturing under one roof, streamlining processes, enhancing safety, and accelerating delivery of high-quality, clinically-ready antibody-drug conjugates.
-
Surface Plasmon Resonance for Biomolecular Interaction Analysis
4/15/2025
Explore how uncovering molecular interactions can drive breakthroughs in disease understanding, drug discovery, and therapeutic innovation.
-
A New Paradigm In T-Cell Lymphoma Treatment: CD5 CAR-NK
4/14/2025
T-cell lymphomas are a complex and increasingly prevalent group of cancers with poor survival outcomes and limited effective treatments, underscoring an urgent need for innovative therapies and novel targets.
-
Case Study: ThioBridge™ Conjugates
4/14/2025
Discover how Abzena’s ThioBridge™ technology is enabling the next generation of stable, scalable, and clinically advanced ADCs through site-specific conjugation.
-
The Path To Regulatory Approval For AOCs
4/14/2025
The development and manufacturability of antibody-oligonucleotide conjugates hinges on understanding and overcoming intricate chemistry and technical challenges.
-
Improve The Design & Delivery Of Your ADC/AOC/RDC With ThioBridge™
4/14/2025
Learn how advanced site-specific conjugation technologies are redefining the next generation of ADCs with enhanced stability, homogeneous DAR, and streamlined development.
-
Optimizing DSP Development: Faster Timelines, Lower Costs, And High-Quality Processes
4/8/2025
The biopharmaceutical industry faces growing downstream processing challenges in purifying complex biologics efficiently and at scale.
-
Optimize Your RNA-LNP Delivery With Ionizable Lipids
4/3/2025
Ionizable lipids play a crucial role in optimizing LNP delivery. Discover how lipid nanoparticles revolutionize intracellular drug delivery to enhance RNA vaccines, cell therapies, protein replacement, and gene editing.
-
Optimal Tech For Predicting Drug Responses At The Cellular Level
4/1/2025
Explore how preserving spatial molecular information and leveraging AI-driven spatial-omics can transform treatment prediction, patient stratification, and personalized medicine.